Dr. Miller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1120 15th St
Augusta, GA 30912Phone+1 706-721-6715
Summary
- Dr. Brian Miller is a psychiatrist in Augusta, GA and is affiliated with Augusta University Medical Center. He received his medical degree from Ohio State University College of Medicine and has been in practice 13 years. He is experienced in schizophrenia and psychotic disorders. He has more than 100 publications and over 500 citings.
Education & Training
- Medical College of GeorgiaResidency, Psychiatry, 2005 - 2010
- Ohio State University College of MedicineClass of 2005
Certifications & Licensure
- GA State Medical License 2008 - 2026
- SC State Medical License 2008 - 2009
- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- An Open-Label Trial of Tocilizumab in Schizophrenia Start of enrollment: 2012 Sep 01
- Tocilizumab in Schizophrenia Start of enrollment: 2016 Sep 01
Roles: Sponsor-Investigator, Principal Investigator, Contact
- Siltuximab in Schizophrenia Start of enrollment: 2016 May 01
Roles: Principal Investigator, Contact, Sponsor-Investigator
Publications & Presentations
PubMed
- 26 citationsTotal and differential white blood cell counts, high-sensitivity C-reactive protein, and cardiovascular risk in non-affective psychosesBrian J. Miller, Prianka K. Kandhal, Mark Hyman Rapaport, Andrew L. Mellor, Peter F. Buckley
Brain, Behavior, and Immunity. 2015-03-01 - 10 citationsTotal and differential white blood cell counts, inflammatory markers, adipokines, and incident metabolic syndrome in phase 1 of the clinical antipsychotic trials of in...Conor W Kelly, Joseph P McEvoy, Brian J Miller
Schizophrenia Research. 2019-07-01 - 115 citationsTowards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future DirectionsBrian J. Miller, David R. Goldsmith
Neuropsychopharmacology. 2017-01-01
Journal Articles
- Insomnia and Suicidal Ideation in Non-Affective PsychosisBrian J Miller, Mark H Rapaport, Peter F Buckley, Sleep
Press Mentions
- Common Blood Test May Provide Insight into Which Patients with Schizophrenia Also at High Risk for Cardiovascular DiseaseSeptember 20th, 2021
- The Latest “Breakthrough Therapy”: Expensive New Drugs for Tardive DyskinesiaNovember 15th, 2020
- Immunotherapy Can Boost Cognitive Function in Schizophrenia PatientsFebruary 29th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: